Rxcrossroads 3PL Llc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Rxcrossroads 3PL Llc Pharmaceutical Import Records from India — 6 Products, $6.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Rxcrossroads 3PL Llc — Pharmaceutical Importer Profile (2026) | 6 Products, $6.4M Trade | TransData Nexus

Rxcrossroads 3PL Llc

Pharmaceutical Importer · United States · Analgesics & Antipyretics Focus · $6.4M Total Trade · DGFT Verified

Rxcrossroads 3PL Llc is a pharmaceutical importer based in United States with a total trade value of $6.4M across 6 products in 5 therapeutic categories. Based on 141 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Rxcrossroads 3PL Llc sources from 11 verified Indian suppliers, with Unichem Laboratories Limited accounting for 37.0% of imports.

Rxcrossroads 3PL Llc — Import Portfolio & Supplier Network

Rxcrossroads 3PL Llc import network — 6 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Rxcrossroads 3PL Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Unichem Laboratories Limited	$4.0M	161	37.0%
Wintac Limited	$2.5M	102	23.3%
Torrent Pharmaceuticals Limited	$982.0K

What Formulations Does Rxcrossroads 3PL Llc Import?

Formulation	Value	Ships
Harmless medicines : tramadol hydrochloridetablets USP 50MG 100ttramadol hcl TAB. USP 50 MG(100t)-usndc	$700.0K	14
Harmless medicines : tramadol hydrochloridetablets USP 50MG 1000ttramadol hcl TAB. USP 50 MG(1000t)-usndc	$472.3K	10
Harmless medicines : tramadol hydrochloridetablets USP 50MG 500ttramadol hcl TAB. USP 50 MG(500t)-usndc	$428.3K	10
Brimonidine tartrate ophthalmic	$391.1K	12
Ephedrine sulfate injection USP 50MG ML 1ML fill in 2ML	$250.0K	5
Dexamethasone sodium phosphate INJ	$240.4K	5
Latanoprost ophthalmic solution	$211.3K	9
Harmless medicines tramadol hydrochloridetablets USP 50MG 100ttramadol hcl TAB USP 50 MG 100t usndc	$200.0K	4
Indian harmless medicines pindolol	$183.4K	5
Latanoprost ophthalmic solution	$174.6K	8
Tropicamide ophthalmic solution USP	$160.2K	8
Tramadol hydrochloride tablets USP 50mg500t tramadol hcl TAB. USP 50 MG (500t)-us ndc code: 2930035505	$158.5K	6
Olopatadine hcl ophthalmic solution	$150.5K	4
Doxorubicin hydrochloride liposome	$150.0K	3
Ephedrine sulfate injection USP 50 MG/ML	$150.0K	3

Rxcrossroads 3PL Llc imports 242 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 6 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Tramadol	Analgesics & Antipyretics	$4.3M	87	0.8%	6
2	Ephedrine	Respiratory & OTC	$700.0K	14	3.1%	4
3	Doxorubicin	Oncology	$600.0K	12	0.9%	7
4	Vati	Ayurvedic & Herbal Products	$369.7K	18	1.4%	15
5	Mitomycin	Advanced Oncology	$200.0K	4	2.5%	2
6	Pemetrexed	Advanced Oncology	$184.9K	6	0.6%	19

Rxcrossroads 3PL Llc imports 6 pharmaceutical products across 5 categories into United States totaling $6.4M.

Rxcrossroads 3PL Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Rxcrossroads 3PL LLC is a third-party logistics (3PL) provider specializing in the importation and distribution of pharmaceutical products within the United States. Established in 2019, the company is headquartered at 4200 Binion Way, Suite 200, Mason, Ohio 45036. The Managing Member is Michele Lau, who can be contacted at (866) 447-9758.

As a 3PL, Rxcrossroads 3PL LLC plays a pivotal role in the U.S. pharmaceutical supply chain by facilitating the importation, storage, and distribution of pharmaceutical formulations sourced from international suppliers, particularly India. The company's operations encompass a range of services, including warehousing, inventory management, and logistics coordination, ensuring the efficient delivery of pharmaceutical products to various stakeholders within the healthcare sector.

2Distribution Network

Rxcrossroads 3PL LLC operates multiple facilities across the United States to support its distribution network. Notable locations include:

Mason, Ohio: The primary headquarters situated at 4200 Binion Way, Suite 200, Mason, Ohio 45036.

Fairdale, Kentucky: A branch located at 1001 Cheri Way, Fairdale, Kentucky 40118.

Erlanger, Kentucky: Another branch situated at 2801 Crescent Springs Pike, Erlanger, Kentucky 41018.

These strategically positioned facilities enable Rxcrossroads 3PL LLC to effectively manage its logistics operations, ensuring timely and reliable distribution of pharmaceutical products across the United States.

3Industry Role

In the U.S. pharmaceutical supply chain, Rxcrossroads 3PL LLC functions as a logistics intermediary. By importing pharmaceutical formulations from international suppliers, particularly India, the company bridges the gap between foreign manufacturers and the U.S. market. This role is crucial in ensuring a steady supply of pharmaceutical products, especially generics, to meet the demands of healthcare providers and patients.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Rxcrossroads 3PL Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Rxcrossroads 3PL LLC demonstrates a high degree of sourcing concentration, with a significant portion of its pharmaceutical imports originating from India. The company's total import value from India amounts to $6.4 million USD, encompassing 141 shipments and 242 unique formulations across six products and five therapeutic categories. This concentration indicates a strategic choice to leverage India's robust pharmaceutical manufacturing capabilities, particularly in the production of generic medications.

The shipment data reveals a stable relationship with key Indian suppliers, including Unichem Laboratories Limited, Wintac Limited, and Torrent Pharmaceuticals Limited. The substantial number of shipments from these suppliers suggests a well-established and reliable supply chain. However, the high concentration also presents a potential risk; any disruptions in India's pharmaceutical manufacturing or export processes could impact Rxcrossroads 3PL LLC's ability to meet U.S. market demands.

2Supply Chain Resilience

Rxcrossroads 3PL LLC's supply chain resilience is closely tied to its reliance on Indian pharmaceutical manufacturers. The company's import portfolio includes 242 unique formulations, indicating a diverse range of products sourced from India. This diversity can mitigate risks associated with dependency on a single product line.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces regulations to ensure that imported drugs meet U.S. standards for safety, efficacy, and quality.

Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which outlines the requirements for drug approval, labeling, and manufacturing practices. Additionally, the Drug Enforcement Administration (DEA) regulates controlled substances, ensuring that imports comply with the Controlled Substances Act.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the U.S. are stringent. Importers must register with the FDA and obtain an Importer of Record number. Each imported drug must be accompanied by a valid New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) approval.

Good Manufacturing Practice (GMP) certification is crucial for ensuring the quality of pharmaceutical products. The FDA recognizes GMP certifications from the European Union (EU GMP), World Health Organization (WHO GMP), and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must verify that their foreign suppliers hold valid GMP certifications from recognized authorities to ensure compliance with U.S. standards.

Rxcrossroads 3PL Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Rxcrossroads 3PL LLC's focus on importing pharmaceutical formulations in the analgesics and antipyretics, respiratory and over-the-counter (OTC), and oncology therapeutic categories aligns with market demand for these essential medications. The substantial import value of tramadol, ephedrine, and doxorubicin indicates a strategic emphasis on pain management, respiratory treatments, and cancer therapies.

Market demand for these products is driven by the prevalence of chronic pain conditions, respiratory diseases, and cancer, necessitating a consistent supply of effective treatments. By concentrating on these therapeutic areas, Rxcrossroads 3PL LLC positions itself to meet critical healthcare needs within the U.S. market.

2Sourcing Profile

Rxcrossroads 3PL LLC's sourcing strategy centers on importing generic pharmaceutical formulations from India. The company's portfolio includes a diverse range of products across multiple therapeutic categories, indicating a preference for a broad selection of formulations to cater to various patient needs.

India's established pharmaceutical manufacturing sector, recognized for its compliance with international GMP standards, makes it a strategic partner for sourcing high-quality generic drugs. Rxcrossroads 3PL LLC's sourcing profile reflects a commitment to providing cost-effective and reliable pharmaceutical products to the U.S. market.

Market Positioning

Seller's Guide — How to Become a Supplier to Rxcrossroads 3PL Llc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Rxcrossroads 3PL LLC. The company's substantial import volume and diverse product portfolio indicate a continuous need for reliable suppliers to meet the demands of the U.S. market.

Gaps in Rxcrossroads 3PL LLC's current sourcing may exist in specific therapeutic areas or product formulations. Indian exporters can explore these opportunities by

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Rxcrossroads 3PL Llc

What products does Rxcrossroads 3PL Llc import from India?

Rxcrossroads 3PL Llc imports 6 pharmaceutical products across 5 categories. Top imports: Tramadol ($4.3M), Ephedrine ($700.0K), Doxorubicin ($600.0K), Vati ($369.7K), Mitomycin ($200.0K).

Who supplies pharmaceuticals to Rxcrossroads 3PL Llc from India?

Rxcrossroads 3PL Llc sources from 11 verified Indian suppliers. The primary supplier is Unichem Laboratories Limited (37.0% of imports, $4.0M).

What is Rxcrossroads 3PL Llc's total pharmaceutical import value?

Rxcrossroads 3PL Llc's total pharmaceutical import value from India is $6.4M, based on 141 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Rxcrossroads 3PL Llc focus on?

Rxcrossroads 3PL Llc imports across 5 categories. The largest: Analgesics & Antipyretics (67.7%), Respiratory & OTC (11.0%), Oncology (9.4%).

Get Full Rxcrossroads 3PL Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.